Table 1.
Groups | Doses (g/kg) | Animals |
Tumor weight/g | (fa)1,2 | (fb)1,2 | Synergistic effects | |
---|---|---|---|---|---|---|---|
Day 0 | Day 11 | ||||||
Control | 8 | 8 | |||||
Model | 8 | 7 | 1.32 ± 0.22 | ||||
CTX | 0.05 | 8 | 7 | 0.36 ± 0.056 | 73.06 | ||
BXT | 2.07 | 8 | 7 | 1.01 ± 0.18 | 23.45 | ||
HWKL-D | 1.6875 | 8 | 8 | 0.69 ± 0.098 | 47.48 | ||
HWKL-Z | 3.375 | 8 | 8 | 0.66 ± 0.10 | 50.11 | ||
HWKL-G | 6.75 | 8 | 8 | 0.55 ± 0.092 | 58.45 | ||
CTX + BXXXT | 0.05 + 2.07 | 8 | 7 | 0.48 ± 0.012 | 79.38 | 63.71 | No |
CTX + HWKL-D | 0.05 + 1.6875 | 8 | 8 | 0.24 ± 0.045 | 85.85 | 81.48 | No |
CTX + HWKL-Z | 0.05 + 3.375 | 8 | 8 | 0.23 ± 0.029 | 86.56 | 82.33 | No |
CTX + HWKL-G | 0.05 + 6.75 | 8 | 8 | 0.14 ± 0.021 | 88.81 | 89.53 | Yes |
(fb)1,2 was the actual inhibitory rate of drug 1with drug 2.
Synergistic effect was considered to be existed if (fb)1,2 was larger than (fa)1,2.